logo

For the Inventor, By the Inventor

Riom, France

Roland Yves Mauvernay

This inventor holds 8 USPTO granted patents. Top assignees: Centre Europeen De Recherches Mauvernay, Centre Europeen De Recherches Mauvernay 'Cerm', Centre European De Recherches Mauvernay. Active years: 1976-1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Yves Mauvernay. Retrieved from https://idiyas.com/inventor/roland-yves-mauvernay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 65(Granted Patents)


Location History:

  • 63201 Riom, FR (1976)
  • Riom, FR (1976 - 1978)

Company Filing History:

goldMedal4 out of 6 
 
Centre Europeen De Recherches Mauvernay
 patents
silverMedal2 out of 5 
 
Centre Europeen De Recherches Mauvernay 'Cerm'
 patents
bronzeMedal1 out of 1 
 
Centre European De Recherches Mauvernay
 patent
4. 1 out of 834,601 
Other
 patents

Years Active: 1976-1978

Loading Chart...
8 patents (USPTO):Explore Patents
1. 4105785 - Anti-depressive (1978-08-08),
2. 4086352 - Certain 6-aryloxy-2-oxo-1-aza-4-thia-spiro[4,5]decanes (1978-04-25),
3. 4062956 - Substituted 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines and quaternary (1977-12-13),
4. 4035498 - Pharmaceutically active compounds and the preparation thereof (1977-07-12),
5. 4029790 - 1-Benzoyl-2 or 4 [2-(4-phenyl-piperazino)-ethyl]-piperidines (1977-06-14),
6. 3993639 - Heptaminol adenosine-5'-monophosphate (1976-11-23),
7. 3962238 - Ethers of n-propanol amine (1976-06-08),
8. 3936450 - Anti-inflammatory agents and method for their preparation (1976-02-03),

Title: The Innovative Contributions of Roland Yves Mauvernay

Introduction

Roland Yves Mauvernay is a notable inventor based in Riom, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address depressive syndromes and enhance cognitive functions. With a total of 8 patents to his name, Mauvernay's work reflects a commitment to advancing medical science.

Latest Patents

Mauvernay's latest patents include innovative compounds that have potential therapeutic applications. One of his notable inventions is an anti-depressive compound, specifically substituted methyl-2-[(dimethylamino-3')propylidene]-4-dihydro-9,10-benzo-[4,5]cyclohepta[1,2-b]-furan. This compound is designed to be effective in treating depressive syndromes and can be synthesized through cyclization from substituted derivatives of furan. Another significant patent involves novel 6-aryloxy-2-oxo-1-aza-4-thia-spiro[4,5]decane compounds. These compounds are represented by a specific formula and are useful as stimulating agents for vigilance, psycho-stimulators, and genesic stimulators.

Career Highlights

Throughout his career, Mauvernay has been associated with various research institutions, including the Centre Européen de Recherches Mauvernay. His work has focused on the synthesis and application of chemical compounds that have the potential to improve mental health and cognitive performance.

Collaborations

Mauvernay has collaborated with notable individuals in his field, including Jacques Moleyre and Norbert Busch. These collaborations have likely contributed to the innovative nature of his work and the successful development of his patented compounds.

Conclusion

Roland Yves Mauvernay's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving mental health and cognitive function. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…